What are the causes of Mobitz type II (second-degree) atrioventricular (AV) block rhythm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Mobitz Type II Atrioventricular Block

Mobitz type II second-degree atrioventricular block is primarily caused by structural heart disease, particularly ischemic heart disease, and is located within or below the His bundle in the His-Purkinje system. 1

Pathophysiological Location and Characteristics

  • Mobitz type II block occurs within or below the His bundle in the His-Purkinje system, unlike Mobitz type I which typically occurs at the AV node 1
  • This block is characterized by sudden failure of conduction without progressive PR prolongation before the blocked beat 1
  • It is associated with a slower and more unpredictable ventricular escape mechanism 1
  • Mobitz type II block does not respond to atropine but may sometimes improve with catecholamines 1
  • It has greater potential to progress rapidly and unexpectedly to complete heart block 1, 2

Primary Causes

Structural Heart Disease

  • Ischemic heart disease, particularly acute myocardial infarction 1, 2
  • Chronic ischemic cardiomyopathy 1
  • Degenerative conduction system disease (Lev's and Lenegre's diseases) 1, 2
  • Cardiac surgery, especially valve surgery 1
  • Transcatheter aortic valve replacement (TAVR) 1
  • Alcohol septal ablation 1

Inflammatory and Infiltrative Conditions

  • Myocarditis 1, 2
  • Lymphoma 1
  • Infiltrative cardiomyopathy 2
  • Cardiac valvular calcification 2

Neuromuscular Diseases

  • Myotonic dystrophy 1
  • Kearns-Sayre syndrome 1
  • Erb's dystrophy 1

Medication-Related Causes

  • Antiarrhythmic drugs 1
  • Beta blockers (less common than in Mobitz type I) 1
  • Calcium channel blockers (less common than in Mobitz type I) 1
  • Digoxin toxicity 1, 2

Metabolic/Endocrine Disorders

  • Hyperkalemia 2
  • Thyroid disease (both hypothyroidism and hyperthyroidism) 1
  • Adrenal disease (e.g., pheochromocytoma, hypoaldosteronism) 1

Iatrogenic Causes

  • Catheter ablation 1

Clinical Significance and Management

  • Mobitz type II block is generally considered more serious than Mobitz type I block due to its location and higher risk of progression to complete heart block 1, 2
  • It is often an indication for permanent pacemaker implantation, regardless of symptoms 1, 2
  • In athletes with Mobitz type II block, comprehensive evaluation including echocardiogram and stress testing is recommended 1
  • Electrophysiological studies may be required to distinguish 2:1 Wenckebach physiology from true Mobitz type II block 1

Diagnostic Considerations

  • A 12-lead ECG is essential for diagnosis, with attention to QRS morphology (often wide) 1
  • Careful evaluation is needed to distinguish true Mobitz type II block from pseudo-AV block caused by concealed His bundle or ventricular extrasystoles 3, 4
  • In cases with 2:1 AV block, it cannot be classified as Mobitz I or II based on surface ECG alone, and the level of block must be determined by other means 1, 4
  • Electrophysiological studies may be necessary in selected cases to confirm the site of block 1, 4

Important Distinctions

  • Unlike Mobitz type I block, Mobitz type II is rarely associated with increased vagal tone 1, 5
  • Mobitz type II block has not been reported in inferior myocardial infarction, where type I block is more common 4
  • The presence of bundle branch block with Mobitz type II block suggests more extensive conduction system disease 1, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.